Patent details

Basic Information

Publication number:

EP0911033

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP991001975

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

French Title of Invention:

Utilisation d'interf?ron consensus pour r?duire les effets secondaires du traitement des h?patites virales par l'interf?ron.

German Title of Invention:

Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.

SPC Number:

Dates

Filing date:

14/04/1993

Grant date:

26/11/2003

EP Publication Date:

26/11/2003

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/04/1999

EP B1 Publication Date:

26/11/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/04/2013

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/04/1993

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Agent

1

Name:

OFFICE FREYLINGER S.A.

From:

11/02/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

2

Name:

KIRKPATRICK SA / NV

From:

18/01/2010

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

Taylor Milton W.

Address:

United States (US)

2

Name:

Blatt Lawrence M.

Address:

United States (US)

Priority

Priority Number:

868916

Priority Date:

15/04/1992

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/21;

Filing date	Document type	Number of pages